FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

TATVA CHINTAN PHARMA CHEM LTD.

NSE : TATVABSE : 543321ISIN CODE : INE0GK401011Industry : ChemicalsHouse : Private

BSE1198.0516.6 (+1.41 %)

PREV CLOSE (Rs.) 1181.45

OPEN PRICE (Rs.) 1172.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2636

TODAY'S LOW / HIGH (Rs.)1167.05 1238.40

52 WK LOW / HIGH (Rs.)610 1603.6

NSE1197.2013.3 (+1.12 %)

PREV CLOSE( Rs. ) 1183.90

OPEN PRICE (Rs.) 1178.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 85218

TODAY'S LOW / HIGH(Rs.) 1166.60 1241.30

52 WK LOW / HIGH (Rs.)621 1610

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

31.82

Dividend Yield(%)

0.08

TTM EPS (Rs.)

13.32

P/E Ratio

89.96

Book Value (Rs.)

320.15

Face Value (Rs.)

MCap (Rs. in Mn)

28024.85

Price/Earning (TTM)

42.79

Price/Sales (TTM)

5.95

Price/Book (MRQ)

3.74

PAT Margin (%)

0.09

ROCE (%)

0.26

Incorporation Year : 12-06 1996

Management Info :

Chintan Nitinkumar Shah - Chairman Chintan Nitinkumar Shah - Managing Director

Registered Office :

Address : Plot No 502/17,G I D C Estate,Ankleshwar,
Bharuch,
Gujarat-393002

Phone : 07574848533 / 34

Email : cs@tatvachintan.com

Website : www.tatvachintan.com

Registrars Details :

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

22Jan Tatva Chintan Pharma Chem informs abou
Pursuant to regulation 30 and 47 of the Securities and Exchange Board of..

26Dec Tatva Chintan Pharma Chem informs abou
Tatva Chintan Pharma Chem has informed that the ‘Trading Window’ for dea..

11Nov Tatva Chintan Pharma Chem informs abou
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

Financials

	QTR Dec 25	ANNUAL 25
Net Profit	159.84	3.27000000000018
Gross Profit	187.92	4.61000000000018
Operating Profit	283.52	294.05
Net Sales	1385.88	3664.15

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Titan Bio-Tech (BSE)

1212.15 (6.53%)

M.Cap (Rs. in Cr)1001.68

Platinum Industries (BSE)

241.55 (4.75%)

M.Cap (Rs. in Cr)1326.71

Gujarat Fluorochemic (BSE)

3397.00 (0.31%)

M.Cap (Rs. in Cr)37316.05

Advance Petro (BSE)

143.70 (4.97%)

M.Cap (Rs. in Cr)12.93

Shareholding Pattern

	PROMOTERS	72.02%
	NON-INSTITUTION	20.48%
	MUTUAL FUNDS/UTI	3.25%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

ICICI Pru MNC Fund(G)

0.95

Nippon India ELSS T...

0.47

ICICI Pru Smallcap ...

0.22

ICICI Pru Commoditi...

0.19

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22